Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What is the Anticipated CAGR of the Iliac Stent Market, and What Factors Will Drive It?

The market size for iliac stents has been experiencing robust growth in the past few years. The market is expected to increase from $1.02 billion in 2024 to $1.09 billion in 2025, with a compound annual growth rate (CAGR) of 6.5%. Factors such as the expansion of the worldwide healthcare sector, heightened awareness about minimal invasive procedures, amplified demand for stenting procedures, increased occurrences of iliac artery ailments, and enhanced healthcare infrastructure have all contributed to growth during the historic period.

In the coming years, the market size of iliac stents is projected to experience robust growth, reaching $1.41 billion in 2029 with a composite annual growth rate (CAGR) of 6.8%. This anticipated growth can be credited to the rising prevalence of peripheral artery diseases, an increasing elderly population, an escalation in the number of angioplasty procedures, a heightened demand for less invasive procedures, and a surge in diabetes incidences. Key trends during the projection period encompass advancements in iliac stent technology, an increase in product approvals, progress in medical technology, the expansion of distribution networks, and the employment of iliac stents in outpatient facilities.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15827&type=smp

What are the Fundamental Drivers and Innovations Shaping the Iliac Stent Market?

The rise in the number of peripheral artery diseases is anticipated to fuel the expansion of the iliac stent market in the future. Peripheral artery disease (PAD) is a vascular disorder marked by the constriction or obstruction of arteries outside the heart and brain. The rise in peripheral artery diseases can be attributed to factors such as smoking, the aging demographic, high blood pressure, and diabetes. Iliac stenting serves as an efficient treatment approach for PAD patients. It not only enhances blood circulation, but also provides relief from symptoms, prevents complications, and is minimally invasive with a high rate of success. As per the Society For Cardiovascular Angiography And Interventions, a US-based organization, in July 2023, PAD is projected to affect 8-10 million Americans annually, and around 19 million Americans are expected to have PAD by 2050. Thus, the rising prevalence of peripheral artery diseases is what’s driving the growth of the iliac stent market.

How Is the Iliac Stent Market Segmented?

The iliac stentmarket covered in this report is segmented –

1) By Type: Self-Expandable Stents, Balloon-Expandable Stents, Other Types

2) By Artery Lesions: Common Iliac Artery Lesions, Severe Calcified Lesions, Complete Obstructive Lesions

3) By End-Users: Hospitals, Outpatient Facilities, Other End-Users

Subsegments:

1) By Self-Expandable Stents: Nitinol Self-Expandable Stents, Polymer-Coated Self-Expandable Stents

2) By Balloon-Expandable Stents: Bare-Metal Balloon-Expandable Stents, Drug-Eluting Balloon-Expandable Stents

3) By Other Types: Covered Stents, Hybrid Stents

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=15827&type=smp

Which Regions Are Driving the Next Phase of the Iliac Stent Market Growth?

North America was the largest region in the iliac stent market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the iliac stent market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

What Key Trends Are Shaping the Future of the Iliac Stent Market?

Key players in the iliac stent market, such as iCast, are focusing on the development of pioneering products to enhance patient results and lessen complication risks. The iCast-covered stent system embodies a revolutionary method for the treatment of iliac artery occlusive disease, providing superior performance and a lower risk of complications compared to conventional bare-metal stents. In October 2023, Getinge, a healthcare firm based in Sweden, unveiled the commercial availability of the iCast-covered stent system, approved by the FDA for the treatment of iliac arterial occlusive disease in the USA. This development underscores Getinge’s dedication to delivering high-quality products and support to US clinicians and hospital systems for managing this serious condition.

View the full report here:

https://www.thebusinessresearchcompany.com/report/iliac-stent-global-market-report

How Is the Iliac Stent Market Defined and What Are Its Core Parameters?

Iliac stents are specialized medical devices designed to treat atherosclerosis in the iliac arteries, which are located in the pelvic region. These stents are deployed through minimally invasive procedures such as angioplasty to expand and support narrowed or blocked arteries.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15827

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model